Dow Gains Over 100 Points; Accenture Shares Plunge After Q2 Results - Accenture (NYSE:ACN)

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 100 points on Thursday.

Following the market opening Thursday, the Dow traded up 0.25% to 42,070.99 while the NASDAQ climbed 0.37% to 17,817.11. The S&P 500 also rose, gaining, 0.28% to 5,689.83.

Check This Out: Tesla To $450? Here Are 10 Top Analyst Forecasts For Thursday

Leading and Lagging Sectors

Consumer discretionary shares rose by 0.7% on Thursday.

In trading on Thursday, materials shares fell by 0.3%.

Top Headline

Shares of Accenture Plc (NYSE:ACN) fell more than 7% on Thursday after the company reported results for the second quarter.

The company reported second-quarter 2025 earnings of $2.82 per share, slightly above the consensus of $2.81. The company reported sales of $16.66 billion, almost in line with the consensus of $16.62 billion and management guidance of $16.2 billion–$16.8 billion.

Accenture narrowed its fiscal year 2025 revenue growth outlook to 5%-7% in local currency, compared to prior guidance of 4%-7%. The company forecasts 2025 diluted earnings of $12.55-$12.79 per share compared to the consensus of $12.90.

Equities Trading UP

SAG Holdings Limited (NASDAQ:SAG) shares shot up 107% to $1.3995.
Shares of Windtree Therapeutics, Inc. (NASDAQ:WINT)got a boost, surging 59% to $2.6900 after the company entered a license and supply agreement to become a sourcing partner for Evofem Biosciences for Evofem’s PHEXXI.
OptiNose, Inc. (NASDAQ:OPTN) shares were also up, gaining 57% to $9.39 after Paratek Pharmaceuticals announced it will acquire the company in a deal worth $330 million.

Equities Trading DOWN

Elevation Oncology, Inc. (NASDAQ:ELEV) shares dropped 47% to $0.2501 after the company announced the discontinued development of EO-3021.
Shares of Benson Hill, Inc. (NASDAQ:BHIL) were down 45% to $0.3570 after the company filed for Chapter 11 bankruptcy.
Adaptimmune Therapeutics plc (NASDAQ:ADAP) was down, falling 31% to $0.3088 after the company issued fourth-quarter and full year 2024 business update.

Commodities

In commodity news, oil traded up 0.5% to $67.50 while gold traded down 0.1% at $3,040.20.

Silver traded down 0.6% to $33.985 on Thursday, while copper fell 0.4% to $5.0815.

Euro zone

European shares were lower today. The eurozone's STOXX 600 fell 0.4%, Germany's DAX 40 fell 1.2% and France's CAC 40 fell 0.8%. Spain's IBEX 35 Index fell 0.9%, while London's FTSE 100 slipped 0.1%.

Asia Pacific Markets

Asian markets closed mixed on Thursday, with China's Shanghai Composite Index falling 0.51%, Hong Kong's Hang Seng Index dipped 2.23% and India's BSE Sensex gaining 1.19%.

Economics

U.S. existing home sales increased by 4.2% from the previous month to an annualized rate of 4.26 million homes in February.
The U.S. current account deficit shrank by 2.0% to $303.9 billion in the fourth quarter, versus a revised deficit of $310.3 billion in the third quarter.
U.S. initial jobless claims increased by 2,000 to 223,000 during the second week of March, compared to market estimates of 224,000.
The Philadelphia Fed Manufacturing Index fell to 12.5 in March from 18.1 in the previous month, versus market estimates of 8.5.

Now Read This:

How To Earn $500 A Month From Micron Technology Stock Ahead Of Q2 Earnings

Photo: Shutterstock

ACNAccenture PLC

$136.00-1.97%

Overview

WINTWINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc.

$0.0120-89.1%

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.